Patients’ perceptions of immunosuppression-related symptom experience impact on quality of life and medication adherence. Using The Modified Transplant Symptom Occurrence and Symptom Distress Scale capturing items on symptom occurrence and symptom distress, 261 heart transplant recipients reported on their symptom experiences. Symptoms occurring with the highest prevalence were tiredness, lack of energy, and nervousness. Men showed erectile dysfunction causing the most distress. Women and younger patients reported significantly higher levels of symptom distress. Distress levels increased with time after transplant. Investigating responses to immunosuppression-related symptom experiences should help develop interventional methods to support long-term outcome.
BuvatJGlasserDNevesRC. (2009) Sexual problems and associated help-seeking behavior patterns: Results of a population based survey in France. International Journal of Urology16(7): 632–638.
2.
Crespo-LeiroMGAlonso-PulponNArizónJM. (2007) Influence of induction therapy immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: Data from the Spanish post-heart transplant tumor registry. Journal of Heart and Lung Transplantation26(11): 1105–1109.
3.
DandelMLehmkuhlHBKnosallaC. (2010) Impact of different long-term maintenance immunosuppressive therapy strategies on patients’ outcome after heart transplantation. Transplant Immunology23(3): 93–103.
4.
De BarrosCTCabritaJ (1999) Self-report of symptom frequency and symptom distress in kidney transplant recipients. Pharmacoepidemiology and Drug Safety8(6): 395–403.
5.
De GeestSMoonsP (2000) The patient’s appraisal of side-effects: The blind spot in quality-of-life assessments in transplant recipients. Nephrology Dialysis Transplantation15(4): 457–459.
6.
De GeestSBorgermansLGemoetsH. (1995) Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation59(3): 340–347.
7.
De Vito DabbsAHoffmanLADauberJH. (2002) Evaluating the reliability and validity of the questionnaire for lung transplant patients. Progress in Transplantation12(3): 191–198.
8.
DobbelsFMoonsPAbrahamI. (2008) Measuring symptom experience of side-effects of immunosuppressive drugs: The Modified Transplant Symptom Occurrence and Distress Scale. Transplant International21(8): 764–773.
9.
DrentGDe GeestSDobbelsF. (2009) Symptom experience, nonadherence and quality of life in adult liver transplant recipients. Netherlands Journal of Medicine67(5): 161–168.
10.
FosterJMVan Der MolenTCaeserM. (2008) The use of questionnaires for measuring patient-reported side effects of drugs: Its importance and methodological challenges. Pharmacoepidemiology and Drug Safety17(3): 278–296.
11.
FrankeGHReimerJKohnleM. (1999) Quality of life in end-stage renal disease patients after successful kidney transplantation: Development of the ESRD symptom checklist—Transplantation module. Nephron83(1): 31–39.
12.
GoetzmannLRueggLStammM. (2008) Psychosocial profiles after transplantation: A 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation86(5): 662–668.
HathawayDWinsettRPrendergastM. (2003) The first report from the patient outcomes registry for transplant effects on life (PORTEL): Differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clinical Transplantation17(3): 183–194.
15.
KuglerCFischerSGottliebJ. (2007) Symptom experience after lung transplantation: Impact on quality of life and adherence. Clinical Transplantation21(5): 590–596.
16.
KuglerCGeyerSGottliebJ. (2009) Symptom experience after solid organ transplantation—A systematic review. Journal of Psychosomatic Research66(2): 101–110.
17.
KuglerCStiefelPRussellCL (2011) Patients’ symptom experiences related to immunosuppression side-effects. In: OppenheimerF (ed.) Compliance in Solid Organ Transplantation. Barcelona: Int’l Transplantation Updates Permanent Publications, pp. 15–33.
18.
KuglerCTegtburUGottliebJ. (2010) Health-related quality of life in long-term survivors after heart and lung transplantation: A comparative cohort study. Transplantation90(4): 451–457.
19.
LanuzaDMMcCabeMNorton-RoskoM. (1999) Symptom experiences of lung transplant recipients: Comparisons across gender, pre-transplantation diagnosis, and type of transplantation. Heart & Lung28(6): 429–437.
20.
LeventhalHDiefenbachMLeventhalEA (1992) Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research16(2): 143–163.
21.
LoboFSGrossCRMattheesBJ (2004) Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients. Quality of Life Research13(2): 377–388.
22.
LoughMELindseyAMShinnJA. (1987) Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart & Lung16(2): 193–200.
23.
MacNaughtonKLRodrigueJRCicaleM. (1998) Health related quality of life and symptom frequency before and after lung transplantation. Clinical Transplantation12(4): 320–323.
24.
MoonsPDe GeestSAbrahamI. (1998) Symptom experience associated with maintenance immunosuppression after heart transplantation: Patient’s appraisal of side effects. Heart & Lung27(5): 315–322.
25.
MoonsPDe GeestSVerstevenK. (2001) Psychometric properties of the “Modified Transplant Symptom Occurrence and Symptom Distress Scale.”Journal of Nursing Measurements9(2): 115–134.
26.
MoonsPVanrenterghemYVan HooffJP. (2003) Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: A multicentre study. Transplant International16(9): 653–664.
27.
MoreiraEDGlasserDBNicolosiA. (2008) Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. British Journal of Urology101(8): 1005–1111.
28.
MyaskovskyLDewMAMcNultyML. (2006) Trajectories of change in quality of life in 12-month survivors of lung or heart transplant. American Journal of Transplantation6(8): 1939–1947.
29.
O’NeillJOEdwardsLBTaylorDO (2006) Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the ISHLT. Journal of Heart and Lung Transplantation25(10): 1186–1191.
30.
OppenheimerFRebolloPGrinyoJM. (2009) Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: A sub-study of the Symphony Study. Transplantation87(8): 1210–1213.
31.
PetersTGSpinolaKNWestJC. (2004) Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation78(4): 537–543.
32.
RhodesVAWatsonPM (1987) Symptom distress, the concept: Past and present. Seminars in Oncology Nursing3(4): 242–247.
33.
RosenbergerJGeckovaAMVan DijkJP. (2005) Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients. Clinical Transplantation19(1): 70–76.
34.
SaeedIRogersCMurdayA (2008) Health-related quality of life after cardiac transplantation: Results of a UK National Survey with norm-based comparisons. Journal of Heart and Lung Transplantation27(6): 675–681.
35.
TaylorDOStehlikJEdwardsLB. (2009) Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplantation Report 2009. Journal of Heart and Lung Transplantation28(10): 1007–1022.
36.
TravisonTGShabsighRAraujoAB. (2007) The natural progression and remission of erectile dysfunction: Results from the Massachusetts male aging study. Journal of Urology177: 241–246.
37.
ÜnalGDe BoerJBBorsboomGJ. (2001) A psychometric comparison of health-related quality of life measures in chronic liver disease. Journal of Clinical Epidemiology54(6): 587–596.
38.
VasiliadisHMColletJPPoirierC (2006) Health-related quality-of-life determinants in lung transplantation. Journal of Heart and Lung Transplantation25(2): 226–233.
39.
WinsettRPArheartKStrattaRJ. (2004) Evaluation of an immunosuppressant side effect instrument. Progress in Transplantation14(3): 210–216.
40.
WinsettRPStrattaRJAllowayR. (2001) Immunosuppressant side effect profile does not differ between organ transplant types. Clinical Transplantation15(6): 46–50.
